Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M504492200 on July 13, 2005

J. Biol. Chem., Vol. 280, Issue 38, 32792-32800, September 23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/38/32792    most recent
M504492200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rouet, V.
Right arrow Articles by Courty, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rouet, V.
Right arrow Articles by Courty, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis*

Vincent Rouet{ddagger}1, Yamina Hamma-Kourbali{ddagger}, Emmanuel Petit§, Panagiota Panagopoulou¶, Panagiotis Katsoris¶, Denis Barritault¶, Jean-Pierre Caruelle{ddagger}, and José Courty{ddagger}2

From the {ddagger}Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires UMR CNRS 7149, Université Paris XII-Val de Marne, Avenue du Général de Gaulle, 94010 Créteil CEDEX, France, the §Organes Tissus Régénération Réparation Remplacement (OTR3), SAS, 4 rue Française, 75001 Paris, and the Division of Genetics, Cell & Development Biology, Department of Biology, University of Patras, GR 26504 Patras, Greece

In a previous study, we showed that in situ injection of glycosaminoglycan mimetics called RGTAs® (ReGeneraTing Agents) enhanced neovascularization after skeletal muscular ischemia (Desgranges, P., Barbaud, C., Caruelle, J. P., Barritault, D., and Gautron, J. (1999) FASEB J. 13, 761–766). In the present study, we showed that the RGTA® OTR4120 modulated angiogenesis in the chicken embryo chorioallantoic membrane assay, in a dose-dependent manner. We therefore investigated the effect of OTR4120 on one of the most specific angiogenesis-regulating heparin-binding growth factors, vascular endothelial growth factor 165 (VEGF165). OTR4120 showed high affinity binding to VEGF165 (Kd = 2.2 nM), as compared with heparin (Kd = 15 nM), and potentiated the affinity of VEGF165 for VEGF receptor-1 and -2 and for neuropilin-1. In vitro, OTR4120 potentiated VEGF165-induced proliferation and migration of human umbilical vein endothelial cells. In the in vivo MatrigelTM plug angiogenesis assay, OTR4120 in a concentration as low as 3 ng/ml caused a 6-fold increase in VEGF165-induced angiogenesis. Immunohistochemical staining showed a larger number of well differentiated VEGFR-2-expressing-cells in MatrigelTM sections of OTR4120-treated plug than in control sections. These findings indicate that OTR4120 enhances the VEGF165-induced angiogenesis and therefore may hold promise for treating disorders characterized by deficient angiogenesis.


Received for publication, April 25, 2005 , and in revised form, July 8, 2005.

* This work was supported in part by Grant 4248 from the Association pour la Recherche sur le Cancer and by grants from the Ministère de l'Education Nationale (DRED) and CNRS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Received a grant from the Ministère de la Recherche et de l'Enseignement Supérieur and is currently employed by Université Paris XII-Val de Marne.

2 To whom correspondance should be addressed: Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires UMR CNRS 7149, Université Paris XII Val de Marne, Ave. du Général de Gaulle, 94010 Créteil CEDEX, France. Tel.: 33-1-45-17-17-97; Fax: 33-1-45-17-18-16; E-mail: courty{at}univ-paris12.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
S. Fischer, M. Nishio, S. C. Peters, M. Tschernatsch, M. Walberer, S. Weidemann, R. Heidenreich, P. O. Couraud, B. B. Weksler, I. A. Romero, et al.
Signaling mechanism of extracellular RNA in endothelial cells
FASEB J, July 1, 2009; 23(7): 2100 - 2109.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. S. Rodgers, S. Lalani, K. M. Hardy, X. Xiang, D. Broka, P. B. Antin, and T. D. Camenisch
Depolymerized Hyaluronan Induces Vascular Endothelial Growth Factor, a Negative Regulator of Developmental Epithelial-to-Mesenchymal Transformation
Circ. Res., September 15, 2006; 99(6): 583 - 589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement